Effective October 15th, the New York Medicare administrator, NGS, added STELARA® J3357 (pre-filled syringe and 45-mg vial) to their Self-Administered Drug list. This change means that patients receiving Stelara injections are not able to have these services covered under Medicare Part B.
Specialty Infusion is working with QuickRx pharmacy to service Medicare patients that are impacted by this change and provide continuity of care at our locations under Medicare Part D. We are also able to accommodate new Medicare patients that have been displaced from their normal injection site. Please contact us or have your physician prescribe here to QuickRx if you are interested in receiving Stelara injections at our Specialty Infusion locations.
Why Use Specialty Infusion Centers?
Highly skilled clinical team able to handle any infusion reaction or medical need
Open 7 days a week with extended hours
Financial savings through co-pay assistance programs
Quick and easy scheduling
All major insurances accepted
Convenient locations
Comfortable and private setting
Wifi, iPads and Netflix with complimentary refreshments
Featured Patient Testimonials
“The staff was top notch. Very friendly and accommodating. The level of cleanliness was superb.”
– Christoper H.
“This place is a life saver! It’s a very relaxing, enjoyable space, and the staff does a great job of making you feel welcome.”
– Alexa S.
“The staff is incredibly kind and makes getting infusions a breeze. Office staff is helpful and on top of things.”
– Jenn L.
“Simply a great all around experience. Facility is very clean (way better than a hospital), feel safe getting infused here, and the coordination team is amazing at being quick with your prior authorization and scheduling. Super responsive and professional team!”
– Richard L.
Interested in Speaking with Someone at a Specialty Infusion Center Near You?
Offering a Wide Range of
Infusion and Injection Treatments
- ADAKVEO
- AMVUTTRA™
- AVSOLA®
- Benlysta
- Cerezyme®
- Cimzia
- Entyvio
- Fabrazyme
- Fasenra
- Gammagard
- Gamunex-C
- Givlaari
- Hizentra
- ILUMYA®
- Inflectra
- Intralipid
- Krystexxa
- Lemtrada
- NAD+
- NEXVIAZYME
- Nulojix
- Ocrevus
- Onpattro
- Orencia
- Privigen
- Radicava
- Remicade
- Renflexis
- Rituxan
- Ruxience
- Simponi Aria
- Skyrizi
- Soliris
- Solu-Medrol
- Stelara IV
- Stelara SQ
- TEPEZZA
- TEZSPIRE
- Truxima
- Tysabri
- ULTOMIRIS
- Uplizna
- VPRIV
- VYVGART
- Xolair
Featured Blog Posts
Stelara: Overview, Side Effects and More
9/7/2022
Stelara, or ustekinumab, is a biological drug used to treat adults and children aged six and older with mild to severe plaque psoriasis, adults with moderate-to-severe psoriatic arthritis, and adults with moderate-to-severe Crohn’s disease and ulcerative colitis by reducing inflammation.
Understanding Copay Accumulators: A Basic Guide
6/23/2022
A copay accumulator, also known as an accumulator adjustment scheme, is used to prevent manufacturer copay assistance coupons used by insurance companies and pharmacy benefit managers (PBMs) from being utilized to cover two prices
